0001209191-20-059443.txt : 20201119 0001209191-20-059443.hdr.sgml : 20201119 20201119170018 ACCESSION NUMBER: 0001209191-20-059443 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201117 FILED AS OF DATE: 20201119 DATE AS OF CHANGE: 20201119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Somaiya Mayur Ian CENTRAL INDEX KEY: 0001760303 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38811 FILM NUMBER: 201329456 MAIL ADDRESS: STREET 1: TCR2 THERAPEUTICS INC. STREET 2: 100 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TCR2 THERAPEUTICS INC. CENTRAL INDEX KEY: 0001750019 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 474152751 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-949-5200 MAIL ADDRESS: STREET 1: 100 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-17 0 0001750019 TCR2 THERAPEUTICS INC. TCRR 0001760303 Somaiya Mayur Ian C/O TCR2 THERAPEUTICS 100 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Financial Officer Common Stock 2020-11-17 4 M 0 2000 5.88 A 5139 D Common Stock 2020-11-17 4 S 0 2000 30.00 D 3139 D Common Stock 2020-11-17 4 S 0 1666 30.00 D 1473 D Stock Option (Right to Buy) 5.88 2020-11-17 4 M 0 2000 0.00 D 2028-04-29 Common Stock 2000 104558 D The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. 25% of this option shall vest and become exercisable on April 9, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. Margaret Siegel as Attorney-in-Fact 2020-11-19